NCT04470180

Brief Summary

This study aims to evaluate the comparative effectiveness of a high-fidelity, low-resource, and feasible model versus a standardized brief intervention that mimics usual care to deliver tailored inhaler technique education to children with asthma via a randomized clinical trial. We have already conducted a trial of V-TTG among elementary school-aged children hospitalized in the inpatient setting and we now aim to test this tool in the outpatient clinic setting among a broader pediatric patient population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 14, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2021

Completed
Last Updated

February 18, 2022

Status Verified

February 1, 2022

Enrollment Period

1.3 years

First QC Date

April 16, 2020

Last Update Submit

February 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of participants with effective inhaler use (>75% steps correct) post-intervention with V-TTG versus BI

    Inhaler technique will be assessed based on a validated published checklist, which was developed and validated by Dr. Press15 and utilized in my preliminary research with children (see Preliminary Studies). For this primary outcome, we will account for the pre-intervention technique to account for any differences in baseline of the two groups

    12 months

Secondary Outcomes (7)

  • Number of inhaler technique steps correct pre- and post-V-TTG education

    At baseline

  • Number of inhaler technique steps correct at 1 month

    1-month after enrollment

  • Score of Asthma Control Survey

    12-months

  • Score of Asthma Impact

    12-months

  • Score of Caregiver Quality of Life

    12-months

  • +2 more secondary outcomes

Study Arms (2)

Virtual Teach-to-Goal (V-TTG)

EXPERIMENTAL

They will be randomized to receive education via a virtual learning module.

Behavioral: Virtual Teach to Goal

standardized brief intervention

ACTIVE COMPARATOR

Intervention that mimics usual care to deliver inhaler technique education.

Behavioral: Brief Instruction

Interventions

Participants will complete inhaler education on a tablet device.

Virtual Teach-to-Goal (V-TTG)

Participants will be read out loud instruction on how to use their inhaler.

standardized brief intervention

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Families will be included in the study if:
  • The child is between the ages of 6-17 years old
  • The child has a diagnosis of asthma, wheezing, or bronchospasm
  • The child has been or is seen in general pediatrics, pediatric pulmonary, or pediatric allergy clinic at the University of Chicago Medical Center
  • The child is taking medication for asthma, wheezing, or bronchospasm (either a controller medication or a quick-relief medication)
  • The family has acess to wifi and/or data that supports virtual video-based platforms (if study is done virtually)

You may not qualify if:

  • Families will be excluded from the study if:
  • The child/parent decline or unable to provide consent/assent
  • The child/parent does not speak/read English
  • The child cannot use an inhaler by themselves without a mask
  • The child previously participated in this study
  • The family does not have access to wifi and/or data that supports virtual video-based platforms (if study done virtually)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medicine

Chicago, Illinois, 60637, United States

Location

Study Officials

  • Anna Volerman, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2020

First Posted

July 14, 2020

Study Start

August 1, 2020

Primary Completion

November 5, 2021

Study Completion

November 5, 2021

Last Updated

February 18, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations